TrialPediatric rheumatology online journal2023

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).

Nobuo Kanazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.